Moreover, the BET anti-proliferative and pro-apoptotic potential has also been investigated in three canine tumor cell lines: T-cell lymphoma (CL-1), B-cell lymphoma (CLBL-1), and osteosarcoma (D-17). This evidence concerns the gene DNER and T-cell non-Hodgkin lymphoma.